Evaluating dietary considerations in hidradenitis suppurativa: a critical examination of existing knowledge

Hidradenitis suppurativa (HS) is a chronic condition that can overwhelm patients, and the effectiveness of supplementary dietary treatments remains uncertain. The primary aim of this review is to explore the connection between diet and HS progression. However, it is imperative to note that the evidence supporting a substantial role of the diet in HS remains weak. Dietary alterations alone should not be considered independent solutions for managing HS. Medical therapy continues to be indispensable for adequate treatment. Research indicates that the Mediterranean lifestyle and diet may provide cost-effective and beneficial adjustments when combined with traditional therapies. Conversely, foods with a high glycemic index and dairy could worsen HS symptoms, conceivably through mechanisms linked to insulin resistance and inflammation. Zinc, known for its antioxidant properties, shows promise as an adjunct therapy. Moreover, evidence suggests a connection between vitamin D deficiency and HS severity, although the findings are inconclusive. Brewer's yeast-free diet, B12 supplementation, intermittent fasting, and reducing the intake of refined sugar and dairy merit further investigation. In conclusion, this review highlights the need for additional research because of the lack of standardized reporting of clinical effects in the studies under scrutiny. A deeper exploration of the pathophysiology focusing on dietary modifications and their potential associations with HS severity is essential. Furthermore, it is crucial to recognize that patients' willingness to experiment with new diets makes them vulnerable to fraudulent interventions, highlighting the importance of evidence-based dietary guidance.

Antibiotic treatment reduces fecundity and nutrient content in females of Anastrepha fraterculus (Diptera: Tephritidae) in a diet dependent way

Insect microbiota, particularly, gut bacteria has recently gained especial attention in Tephritidae fruit flies, being Enterobacteriaceae the predominant bacterial group. This bacterial group has been postulated to contribute to the fitness of fruit flies through several life-history traits. Particularly in Anastrepha fraterculus, removal of Enterobacteria from male gut via antibiotic treatment impaired their mating behavior. Because the impact of gut bacteria on female reproduction was not yet addressed, we here analysed the effect of antibiotic treatment on female fecundity and nutritional status, and further explored the role of bacteria under different dietary regimes. The removal of culturable Enterobacteria from the gut of females was associated to a reduction in fecundity as well as in the protein and lipid reserves. However, fecundity reduction depended on the dietary regime; being more pronounced when females fed a poor diet. Our results suggest that nutrient reserves of females are determined, at least to some extent, by intestinal bacteria (particularly Enterobacteria). The effect of antibiotics on fecundity could be explained, thus, as a consequence of a poorer nutritional status in antibiotic-treated females compared to control females. Our results contribute to understand the interaction between gut bacteria and Tephritidae fruit flies. Considering the relevance of this insect as fruit pest and the widespread use of the sterile insect technique to control them, these findings may lead to practical applications, such as development of efficient mass rearing protocols of A. fraterculus that supplement the adult diet with probiotics.

Acute Effects of Turmeric Extracts on Knee Joint Pain: A Pilot, Randomized Controlled Trial

Turmeric extracts (TEs) have been shown to be suitable as a pain treatment for human joint arthritis. In a pilot, randomized clinical trial, 68 individuals with mild/moderate knee joint pain (KJP) consumed a new formulation of water-soluble TEs and insoluble curcuminoids (B-Turmactive®) or brewer's yeast as a placebo for 1 week. Our hypothesis was that B-Turmactive would have a short-term analgesic effect on KJP measured by the self-reported Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). After 3 days and 1 week, both treatments reduced pain when walking on a flat surface (P < .01), going up or down stairs (P < .001), and sitting or lying (P < .05), but only B-Turmactive reduced pain at night while in bed and in an upright standing position (P < .01). Concerning global KJP, it was reduced by both treatments after 3 days and 1 week of the intervention (P < .001), being less with B-Turmactive after 1 week (P = .012 vs. 3 weeks). Although no intertreatment differences were observed, only B-Turmactive decreased high-sensitivity C-reactive protein levels (P = .045) at 1 week, which indicates a prompt analgesic effect mediated by a decrease in inflammatory status.

Removal of platinum (IV) from aqueous solutions with yeast-functionalised bentonite

There is a need for cheap but, efficient methods for the removal of precious metals from wastewaters, which are normally lost during mineral processing. Moreover, the disposal of yeast waste from brewing has been a problem in many parts of the world. In this study, the removal of Pt(IV) from aqueous solutions using the readily available bentonite clay functionalised with spent yeast from brewing was investigated. The maximum adsorption capacity of Pt(IV) with 100 mg yeast-functionalised bentonite at pH 2 within 90 min was 255 μg g^-1 (98.5% efficiency) but, decreased as pH increased. The adsorption capacity of Pt(IV) was insignificantly (p > 0.05) affected by the presence of competing ions (Fe(III), Ca(II), Mg(II), K(I), Co(II)^, Ni(II), Hf(IV), Zn(II) and other platinum group metals (PGMs)). Moreover, most of these metals were significantly adsorbed along with Pt(IV). The indicative cost-benefit analysis showed that 1 kg of the yeast-functionalised bentonite can remove ∼700 g Pt(IV) in which a profit of more than USD20000 can be made. The bentonite functionalised with spent yeast from brewing has a potential to recover lost PGMs in wastewater. Since, this is a cheap process, the mining and other industries can make much profit from such recoveries.

Dietary yeast hydrolysate and brewer's yeast supplementation could enhance growth performance, innate immunity capacity and ammonia nitrogen stress resistance ability of Pacific white shrimp (Litopenaeus vannamei)

An 8-week feeding trial was conducted to evaluate the effects of dietary yeast hydrolysate and brewer's yeast supplementation on growth, immune-related genes expression and ammonia nitrogen stress resistance of Pacific white shrimp (Litopenaeus vannamei). Three isonitrogenous and isolipidic practical diets were formulated to contain 0% (control diet), 1% yeast hydrolysate and 1% brewer's yeast, respectively. 360 juvenile L. vannamei with an initial weight (0.88 ± 0.01 g) was randomly divided into 3 treatments in four replicates (30 shrimp per replicate). The results indicated that shrimp fed the diet containing 1% yeast hydrolysate had a significantly higher weight gain (WG), and specific growth rate (SGR) than that fed the control diet, and the lowest feed conversion ratio (FCR) was occurred in the 1% yeast hydrolysate supplementation group. Proximate composition in whole body and muscle among all treatments was not significantly influenced by the dietary yeast hydrolysate or brewer's yeast supplementation. The challenge test with ammonia nitrogen showed that lower cumulative survival was observed in those fed the control diet, and the highest cumulative survival was occurred at shrimp fed the 1% yeast hydrolysate supplementation. Shrimp fed the control diet had higher inflammation-related genes expression levels of tnf-α and il-1β in the intestine than those fed the diets supplemented with 1% yeast hydrolysate or 1% brewer's yeast, however, there was no significant difference in expression level of alp in intestine among all treatments. The relative expression levels of mTOR signal pathway genes (eif4ebp, eif4e1a, eif4e2 and p70s6k) were significantly up-regulated in the shrimp fed the diets supplemented with 1% yeast hydrolysate, and the lowest gene expression levels of eif4ebp, eif4e1a, eif4e2 and p70s6k in the intestine were occurred at the control diet. The highest expression levels of the immune-related genes (dorsal, relish, and proPO) in the intestine were observed at shrimp fed the 1% yeast hydrolysate supplementation, and the lowest expression levels of these genes were occurred at shrimp fed the control diet, however, there was no significant difference in gene expression of lysozyme among all treatments. The expression levels of penaeidin3a, crustin, proPO, and IMD in the hepatopancreas were significantly influenced by the dietary yeast hydrolysate, brewer's yeast or no yeast product supplementation, shrimp fed the 1% yeast hydrolysate supplementation had higher expression levels of these genes than those fed the control diet. The present study indicated that dietary 1% yeast hydrolysate or brewer's yeast supplementation could improve growth performance, enhance innate immunity, and strengthen resistance of ammonia nitrogen stress, and dietary 1% yeast hydrolysate supplementation provides better immunostimulatory effects than brewer's yeast of L. vannamei.

Defective quiescence entry promotes the fermentation performance of bottom-fermenting brewer's yeast

One of the key processes in making beer is fermentation. In the fermentation process, brewer's yeast plays an essential role in both the production of ethanol and the flavor profile of beer. Therefore, the mechanism of ethanol fermentation by of brewer's yeast is attracting much attention. The high ethanol productivity of sake yeast has provided a good basis from which to investigate the factors that regulate the fermentation rates of brewer's yeast. Recent studies found that the elevated fermentation rate of sake Saccharomyces cerevisiae species is closely related to a defective transition from vegetative growth to the quiescent (G₀) state. In the present study, to clarify the relationship between the fermentation rate of brewer's yeast and entry into G₀, we constructed two types of mutant of the bottom-fermenting brewer's yeast Saccharomyces pastorianus Weihenstephan 34/70: a RIM15 gene disruptant that was defective in entry into G₀; and a CLN3ΔPEST mutant, in which the G₁ cyclin Cln3p accumulated at high levels. Both strains exhibited higher fermentation rates under high-maltose medium or high-gravity wort conditions (20° Plato) as compared with the wild-type strain. Furthermore, G₁ arrest and/or G₀ entry were defective in both the RIM15 disruptant and the CLN3ΔPEST mutant as compared with the wild-type strain. Taken together, these results indicate that regulation of the G₀/G₁ transition might govern the fermentation rate of bottom-fermenting brewer's yeast in high-gravity wort.

Effect of ethanolic extracts of Justicia neesii Ramam. against experimental models of pain and pyrexia

Objective:

The main objective of this study is to evaluate the analgesic and anti-pyretic activities of ethanolic extracts of Justicia neesii Ramam. by different experimental models.

Materials and Methods:

The analgesic activity of plant extract was evaluated against thermal and chemical stimulus induced by Eddy's hot plate and acetic acid respectively in mice. Brewer's yeast induced pyrexia was used to evaluate the antipyretic activity in rats and TAB vaccine induced pyrexia was used to evaluate the antipyretic activity in rabbits.

Results:

In the hot plate model 400 mg/kg p.o. dose of J. neesii has shown its maximal effect at 3 h. The results are significant (P < 0.05) and comparable to the values of standard drug pentazocine (30 mg/kg i.p.). In acetic acid induced writhing model 400 mg/kg p.o. of plant extracts have shown highly significant activity (P < 0.001) and better than standard drug indomethacin (10 mg/kg p.o.). The 400 mg/kg p.o. dose of plant extract has given significant results against both yeast induced pyrexia and TAB vaccine induced pyrexia (P< 0.01 and 0.05 respectively). These values are comparable to that of paracetamol 100 mg/kg p.o. standard dose.

Conclusion:

This study shows that the ethanol extract of J. neesii has significant analgesic and antipyretic activity.

Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus

BACKGROUND

Brewer's yeast may have beneficial effects on insulin receptors because of itsglucose tolerance factor in diabetic patients. This study was conducted to investigate the effects of brewer's yeast supplementation on glycemic indices in patients with type 2 diabetes mellitus.

METHODS

In a randomized double-blind controlled clinical trial, 84 adults (21 men and 63 women) aged 46.3 ± 6.1 years old with type 2 diabetes mellitus were recruited and divided randomly into two groups: Supplement group receiving brewer's yeast (six 300mg tablets/day, total 1800 mg) and control group receiving placebo (six 300mg tablets/day) for 12 weeks. Body weight, height, body mass index, food consumption (based on 24h food record), fasting blood sugar (FBS), glycosylated hemoglobin, insulin sensitivity, and insulin resistance were measured before and after the intervention. Data analysis was performed using the Statistical Package for Social Sciences (version 18.0).

RESULTS

The changes in FBS, glycosylated hemoglobin, and insulin sensitivity were significantly different between the two groups during the study (respectively P < 0.001, P < 0.001, P = 0.02 independent sample t-test). There was a significant difference in FBS, glycosylated hemoglobin, and insulin sensitivity at the end of the study between the two groups after removing the effects of baseline values (respectively P = 0.002, P < 0.001, P = 0.02, analysis of covariance). Changes in body mass index, 24h food record, insulin resistance were not significant.

CONCLUSIONS

Dietary supplementation with brewer›s yeast besides the usual treatment of diabetes can ameliorate blood glucose variables in type 2 diabetes mellitus.

Antipyretic activity of Guduchi Ghrita formulations in albino rats

The present pharmacological investigation was undertaken to study the anti-pyretic activity of Guduchi ghrita formulations in albino rats against yeast induced pyrexia. Seven groups of six animals were used for the experiment. The yeast induced pyrexia method was standardized first by injecting 12.5% yeast suspension (s.c) followed by recording the rectal temperature at regular intervals. Then the evaluation of anti-pyretic activity of Guduchi ghrita formulations was carried out by using this standard procedure. Both the Guduchi ghrita samples including vehicle significantly attenuated the raise in temperature after three hours of yeast injection. After 6 and 9 hours of yeast injection also both the Guduchi ghrita samples attenuated the raise in temperature in a highly significant manner in comparison to both yeast control and vehicle control groups. The data generated during study shows that both the Guduchi ghrita formulations having significant anti-pyretic activity.

Preliminary investigation on antipyretic activity of cuscuta reflexa in rats

In present study, the antipyretic activity of aqueous and ethanol extracts from Cuscuta reflexa Roxb. (Cuscutaceae) was evaluated using Brewer's yeast induced pyrexia in rats. Both the extracts at 200 and 400 mg/kg body weight dose significantly (p < 0.05) reduced the increased rectal temperature. The extracts started reducing the elevated rectal temperature after 3 h of treatment in a dose related manner. At the dose of 400 mg/kg body weight the aqueous and ethanol extract reduced 79 % and 83.8 % respectively of the elevated rectal temperature as compared to reference drug paracetamol (96.5 %) after 6 h of treatment. It was therefore concluded that both the extracts of C. reflexa demonstrated antipyretic activity, the ethanol extract was found to be slightly potent than the aqueous extract.